
The Microeconomics of Despair in Sudan
Hyperinflation and state collapse leave chronic disease patients navigating absurd daily financial calculations.

When a state apparatus implodes, the deadliest metric is rarely recorded in real-time battle maps. Instead, it surfaces in the quiet, absurd arithmetic of daily survival. In Sudan, conflict between the armed forces and the Rapid Support Forces has achieved a comprehensive destruction of basic infrastructure, dragging real income levels back to the 1990s according to United Nations Development Programme estimates. The resulting collapse has reduced the management of chronic disease to a series of impossible economic choices.
Consider the mechanics of the failure. According to the National Medical Supplies Fund, the war has inflicted an estimated $500 million in losses on pharmaceutical stocks, transport fleets, and health infrastructure. Domestic production has virtually ceased: the National Medicines and Poisons Board reports that merely eight of Khartoum’s thirty pharmaceutical factories are currently operational. To compensate, the country relies almost entirely on imports, precisely at a moment when the Sudanese pound has experienced a catastrophic devaluation, plummeting from 600 to the dollar before the war to 9,300 on the black market.
The institutional safety nets have dissolved alongside the currency. Before the conflict, state schemes like the National Health Insurance Fund covered up to 75 percent of essential drug costs for enrolled citizens. Today, those welfare mechanisms are defunct. Families relying on casual day-labour must now absorb the full force of hyperinflation to secure basic treatments for conditions such as hypertension, heart disease, and diabetes.
This fiscal ruin produces bizarre economic paradoxes on the ground. A diabetic patient forced to choose between a 70,000-pound insulin pen and a 17,000-pound vial will routinely pick the latter due to a lack of upfront cash—even though maintaining the vial without a working refrigerator requires spending 180,000 pounds a month on ice. Spread over thirty days, the inferior option costs far more, yet cash-strapped citizens have no choice but to pay the daily surcharge.
The distortion extends to the supply side. Pharmacists in safer enclaves like Port Sudan report buying new inventory at wholesale prices that match their previous retail tags, effectively wiping out profit margins needed to keep their doors open. Meanwhile, patients across conflict zones like North Kordofan are forced to manage strict, life-critical medication schedules while relying on informal transport networks from other cities just to obtain a single month's supply.
When war destroys production, bankrupts insurance funds, and renders money worthless, healthcare ceases to be a system. It becomes an unmanageable luxury, leaving millions to calculate whether they can afford tomorrow's pills or tomorrow's bread.
Written by Sandy van Dongen sandy.vandongen@alpineweekly.com




